Monica A Munoz

Monica A Munoz,

CO AST PROF

Department: Pharmaceutical Outcomes & Policy
Business Phone: (301) 796-3698
Business Email: monica.munoz@ufl.edu

Research Profile

Open Researcher and Contributor ID (ORCID)

Publications

2023
Monitoring Drug Safety in Pregnancy with Scan Statistics: A Comparison of Two Study Designs.
Epidemiology (Cambridge, Mass.). 34(1):90-98 [DOI] 10.1097/EDE.0000000000001561. [PMID] 36252086.
2023
Novel methods for pregnancy drug safety surveillance in the FDA Sentinel System.
Pharmacoepidemiology and drug safety. 32(2):126-136 [DOI] 10.1002/pds.5512. [PMID] 35871766.
2021
Food and Drug Administration Beyond the 2001 Government Accountability Office Report: Promoting Drug Safety for Women.
Journal of women's health (2002). 30(7):927-934 [DOI] 10.1089/jwh.2020.8380. [PMID] 33635140.
2020
Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.
Pharmacotherapy. 40(11):1099-1107 [DOI] 10.1002/phar.2468. [PMID] 33090530.
2019
Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System.
The Annals of pharmacotherapy. 53(9):962-963 [DOI] 10.1177/1060028019849664. [PMID] 31055957.
2017
Harnessing scientific literature reports for pharmacovigilance. Prototype software analytical tool development and usability testing.
Applied clinical informatics. 8(1):291-305 [DOI] 10.4338/ACI-2016-11-RA-0188. [PMID] 28326432.

Contact Details

Phones:
Business:
(301) 796-3698
Emails:
Addresses: